Share
PDF
Other content recommended for you
- Spinal muscular atrophy – type I
- Nusinersen for SMA: expanded access programme
- Outcome of goal - directed non-invasive ventilation and mechanical insufflation / exsufflation in spinal muscular atrophy type I
- British Thoracic Society guideline for respiratory management of children with neuromuscular weakness
- Healthcare utilisation in children with SMA type 1 treated with nusinersen: a single centre retrospective review
- Protocol for a phase II, monocentre, double - blind, placebo - controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial)
- Spinal muscular atrophy: untangling the knot?
- Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0–4
- Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives
- Congenital heart disease is a feature of severe infantile spinal muscular atrophy